Type of therapy | Number of patients | % |
---|---|---|
Empirical antibiotic therapies | 539 | 100% |
   Amoxicillin/clavulanate | 223 | 41.4% |
   Ciprofloxacin | 88 | 16.3% |
   Piperacillin/tazobactam | 55 | 10.2% |
   Amoxicillin/clavulanate + clarithromycin | 33 | 6.1% |
   Ceftriaxone | 23 | 4.3% |
   Cefepime + amikacin | 18 | 3.3% |
   Amoxicillin/clavulanate + amikacin | 12 | 2.2% |
   Ciprofloxacin + metronidazole | 9 | 1.7% |
   Trimethoprim/sulfamethoxazole | 6 | 1.1% |
   Norfloxacin | 6 | 1.1% |
   Cefepime | 5 | 0.9% |
   Ceftriaxone + clarithromycin | 5 | 0.9% |
   Other antibiotics or antibiotic combinations | 56 | 10.4% |
Adjusted antibiotic therapies | 168 | 100% |
   Amoxicillin/clavulanate | 29 | 17.3% |
   Piperacillin/tazobactam | 22 | 13.1% |
   Ciprofloxacin | 15 | 8.9% |
   Penicillin | 12 | 7.1% |
   Amoxicillin/clavulanate + ciprofloxacin | 8 | 4.8% |
   Amoxicillin/clavulanate + clarithromycin | 6 | 3.6% |
   Meropenem | 5 | 3.0% |
   Cefuroxime | 5 | 3.0% |
   Other antibiotics or antibiotic combinations a | 66 | 39.3% |